SE9704404D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9704404D0
SE9704404D0 SE9704404A SE9704404A SE9704404D0 SE 9704404 D0 SE9704404 D0 SE 9704404D0 SE 9704404 A SE9704404 A SE 9704404A SE 9704404 A SE9704404 A SE 9704404A SE 9704404 D0 SE9704404 D0 SE 9704404D0
Authority
SE
Sweden
Prior art keywords
new compounds
prevention
substituted
formula
treatment
Prior art date
Application number
SE9704404A
Other languages
English (en)
Swedish (sv)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9704404A priority Critical patent/SE9704404D0/xx
Publication of SE9704404D0 publication Critical patent/SE9704404D0/xx
Priority to ZA9810468A priority patent/ZA9810468B/xx
Priority to TW087118942A priority patent/TW515798B/zh
Priority to ARP980105799A priority patent/AR016972A1/es
Priority to MYPI98005216A priority patent/MY121032A/en
Priority to CNB98813344XA priority patent/CN1142933C/zh
Priority to HU0100601A priority patent/HUP0100601A3/hu
Priority to SK674-2000A priority patent/SK283904B6/sk
Priority to AT98957270T priority patent/ATE233263T1/de
Priority to UA2000052801A priority patent/UA70932C2/uk
Priority to CZ20001947A priority patent/CZ292349B6/cs
Priority to SI9830381T priority patent/SI1042324T1/xx
Priority to US09/194,823 priority patent/US6518270B1/en
Priority to IDW20000987A priority patent/ID24730A/id
Priority to IL13614598A priority patent/IL136145A0/xx
Priority to JP2000523214A priority patent/JP2001525322A/ja
Priority to PCT/SE1998/002091 priority patent/WO1999028322A1/en
Priority to ES98957270T priority patent/ES2191356T3/es
Priority to EP98957270A priority patent/EP1042324B1/en
Priority to PL98340920A priority patent/PL340920A1/xx
Priority to TR2000/01530T priority patent/TR200001530T2/xx
Priority to EEP200000315A priority patent/EE04060B1/xx
Priority to AU13565/99A priority patent/AU752187C/en
Priority to HK01101145.1A priority patent/HK1030216B/en
Priority to RU2000113729/04A priority patent/RU2241000C2/ru
Priority to NZ504355A priority patent/NZ504355A/en
Priority to PT98957270T priority patent/PT1042324E/pt
Priority to BR9814755-2A priority patent/BR9814755A/pt
Priority to KR1020007005804A priority patent/KR20010032559A/ko
Priority to CA002311798A priority patent/CA2311798A1/en
Priority to DK98957270T priority patent/DK1042324T3/da
Priority to DE69811735T priority patent/DE69811735T2/de
Priority to IS5486A priority patent/IS5486A/is
Priority to NO20002721A priority patent/NO315704B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9704404A 1997-11-28 1997-11-28 New compounds SE9704404D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds
ZA9810468A ZA9810468B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion processes for their preparation and pharmaceutical compositions thereof
TW087118942A TW515798B (en) 1997-11-28 1998-11-16 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
ARP980105799A AR016972A1 (es) 1997-11-28 1998-11-16 Compuestos heterociclicos sustituidos con bencilo para la inhibicion de secrecion de acido gastrico, procesos para su preparacion, composicionesfarmaceuticas y uso de los mismos
MYPI98005216A MY121032A (en) 1997-11-28 1998-11-17 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
DE69811735T DE69811735T2 (de) 1997-11-28 1998-11-18 Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
PCT/SE1998/002091 WO1999028322A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
TR2000/01530T TR200001530T2 (tr) 1997-11-28 1998-11-18 Gastrik asit salgılamasının önlenmesi için heterosiklik bileşimler
SK674-2000A SK283904B6 (sk) 1997-11-28 1998-11-18 Heterocyklické zlúčeniny na inhibíciu sekrécie žalúdočnej kyseliny, spôsoby ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
AT98957270T ATE233263T1 (de) 1997-11-28 1998-11-18 Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
UA2000052801A UA70932C2 (uk) 1997-11-28 1998-11-18 Гетероциклічні сполуки для пригнічення кислотності шлункового секрету, спосіб їх одержання (варіанти) та фармацевтична композиція, що їх містить (варіанти)
CZ20001947A CZ292349B6 (cs) 1997-11-28 1998-11-18 Heterocyklická sloučenina, způsoby její přípravy a použití a farmaceutická kompozice s jejím obsahem
SI9830381T SI1042324T1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
US09/194,823 US6518270B1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
IDW20000987A ID24730A (id) 1997-11-28 1998-11-18 Senyawa-senyawa heterosiklik untuk penghambatan sekresi asam lambung, proses pembuatan dan komposisi-komposisi farmasinya
IL13614598A IL136145A0 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
JP2000523214A JP2001525322A (ja) 1997-11-28 1998-11-18 胃酸分泌を抑制する複素環式化合物、それらの製造法およびそれらの医薬組成物
CNB98813344XA CN1142933C (zh) 1997-11-28 1998-11-18 抑制胃酸分泌的杂环化合物、其制备方法及其药物组合物
ES98957270T ES2191356T3 (es) 1997-11-28 1998-11-18 Compuestos heterociclicos para la inhibicion de la secrecion de acidos gastricos, procedimientos para su preparacion y composiciones farmaceuticas de ellos.
EP98957270A EP1042324B1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
PL98340920A PL340920A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds
HU0100601A HUP0100601A3 (en) 1997-11-28 1998-11-18 Bicyclic compounds containing nitrogen, processes for their preparation and pharmaceutical compositions thereof
EEP200000315A EE04060B1 (et) 1997-11-28 1998-11-18 Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised
AU13565/99A AU752187C (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
HK01101145.1A HK1030216B (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
RU2000113729/04A RU2241000C2 (ru) 1997-11-28 1998-11-18 Гетероциклические соединения с замещенной фенильной группировкой, способ их получения (варианты), фармацевтические препараты на их основе и способ ингибирования секреции желудочной кислоты
NZ504355A NZ504355A (en) 1997-11-28 1998-11-18 Imidazopyrazine, pyrrolopyridazine, pyrrolopyridine, pyrrolopyrazine, imidazopyridazine or imidazopyrimidine derivatives substituted by benzoyloxy or benzylamino useful for inhibiting gastric acid secretions
PT98957270T PT1042324E (pt) 1997-11-28 1998-11-18 Compostos heterociclicos para inibicao da secrecaode acido gastrico processis para a sua prepara cao e suas composicoes farmaceuticas
BR9814755-2A BR9814755A (pt) 1997-11-28 1998-11-18 Composto, formulação farmacêutica, uso de um composto, e, processos para a preparação de um composto, para inibir a secreção do ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais, e para o tratamento ou profilaxia de condições que envolvam infecção por helicobacter pylori da mucosa gástrica humana
KR1020007005804A KR20010032559A (ko) 1997-11-28 1998-11-18 위산 분비 억제용 헤테로고리 화합물, 그의 제조 방법 및그의 제약 조성물
CA002311798A CA2311798A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
DK98957270T DK1042324T3 (da) 1997-11-28 1998-11-18 Heterocykliske forbindelser til inhibering af mavesyresekretion, fremgangsmåder til deres fremstilling og farmaceutiske præparater deraf
IS5486A IS5486A (is) 1997-11-28 2000-05-10 Heterósýklísk efnasambönd til að hindra magasýruflæði, aðferðir við framleiðslu þeirra og lyfjablöndur er innihalda þau
NO20002721A NO315704B1 (no) 1997-11-28 2000-05-26 Heterocykliske forbindelser for inhibering av mavesyresekresjon, farmasöytiske preparater inneholdende slike forbindelser, fremgangsmåter forderes fremstilling, og deres anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Publications (1)

Publication Number Publication Date
SE9704404D0 true SE9704404D0 (sv) 1997-11-28

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds

Country Status (32)

Country Link
US (1) US6518270B1 (https=)
EP (1) EP1042324B1 (https=)
JP (1) JP2001525322A (https=)
KR (1) KR20010032559A (https=)
CN (1) CN1142933C (https=)
AR (1) AR016972A1 (https=)
AT (1) ATE233263T1 (https=)
AU (1) AU752187C (https=)
BR (1) BR9814755A (https=)
CA (1) CA2311798A1 (https=)
CZ (1) CZ292349B6 (https=)
DE (1) DE69811735T2 (https=)
DK (1) DK1042324T3 (https=)
EE (1) EE04060B1 (https=)
ES (1) ES2191356T3 (https=)
HU (1) HUP0100601A3 (https=)
ID (1) ID24730A (https=)
IL (1) IL136145A0 (https=)
IS (1) IS5486A (https=)
MY (1) MY121032A (https=)
NO (1) NO315704B1 (https=)
NZ (1) NZ504355A (https=)
PL (1) PL340920A1 (https=)
PT (1) PT1042324E (https=)
RU (1) RU2241000C2 (https=)
SE (1) SE9704404D0 (https=)
SK (1) SK283904B6 (https=)
TR (1) TR200001530T2 (https=)
TW (1) TW515798B (https=)
UA (1) UA70932C2 (https=)
WO (1) WO1999028322A1 (https=)
ZA (1) ZA9810468B (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025429A1 (en) 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
CA2482991A1 (en) 2002-04-19 2003-10-30 Cellular Genomics, Inc. Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
US7312341B2 (en) 2002-09-09 2007-12-25 Cgi Pharmaceuticals, Inc. 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
AU2003266621A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for treatment for or prevention of visceral pain
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
WO2004072081A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
DE602004016831D1 (de) * 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
US7405295B2 (en) 2003-06-04 2008-07-29 Cgi Pharmaceuticals, Inc. Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
US7393848B2 (en) 2003-06-30 2008-07-01 Cgi Pharmaceuticals, Inc. Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
US7259164B2 (en) 2003-08-11 2007-08-21 Cgi Pharmaceuticals, Inc. Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
EP2848614A3 (en) 2004-06-04 2015-07-29 Debiopharm International SA Acrylamide derivatives as antibiotic agents
ATE527258T1 (de) * 2004-07-28 2011-10-15 Takeda Pharmaceutical Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
US20070287726A1 (en) * 2004-08-02 2007-12-13 Altana Pharma Ag 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines
KR100958828B1 (ko) * 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-ｂ]피리딘 유도체 및 그의 제조방법
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
MX2007002214A (es) 2004-09-03 2007-05-07 Yuhan Corp Derivados de pirrolo[3,2-c]piridina y procesos para su preparacion.
ATE466013T1 (de) * 2004-09-03 2010-05-15 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung
WO2007024294A2 (en) 2005-05-03 2007-03-01 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
AR061229A1 (es) * 2006-06-06 2008-08-13 Schering Corp Imidazopirazinas como inhibidores de la proteina quinasa
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
JP5496915B2 (ja) 2008-02-13 2014-05-21 シージーアイ ファーマシューティカルズ，インコーポレーテッド ６−アリール−イミダゾ［１，２−ａ］ピラジン誘導体、その製造方法、及びその使用方法
EA021293B1 (ru) 2008-12-08 2015-05-29 Джилид Коннектикут, Инк. ИМИДАЗОПИРАЗИНОВЫЕ ИНГИБИТОРЫ Syk, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИМИДАЗОПИРАЗИНОВЫЕ ИНГИБИТОРЫ Syk, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
CN102307474B (zh) 2008-12-08 2015-04-01 吉利德康涅狄格股份有限公司 咪唑并吡嗪syk抑制剂
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
CN103168039B (zh) 2010-03-11 2016-08-03 吉利德康涅狄格公司 咪唑并吡啶类syk抑制剂
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
EA029281B1 (ru) 2013-07-30 2018-03-30 Джилид Коннектикут, Инк. Полиморф ингибиторов syk
CA2919522C (en) 2013-07-30 2019-02-26 Gilead Connecticut, Inc. Formulation of syk inhibitors
CN105764516A (zh) 2013-12-04 2016-07-13 吉利德科学公司 治疗癌症的方法
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
BR112016028641A2 (pt) 2014-07-14 2017-08-22 Gilead Sciences Inc ?método para tratar câncer?
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
CA3073871A1 (en) 2017-08-25 2019-02-28 Gilead Sciences, Inc. Polymorphs of syk inhibitors
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113950479A (zh) 2019-02-22 2022-01-18 克洛诺斯生物股份有限公司 作为syk抑制剂的缩合吡嗪的固体形式
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
WO1991017164A1 (de) 1990-04-27 1991-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue pyridazine
US5041442A (en) 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
AU8712191A (en) 1990-10-15 1992-05-20 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazines
US5534515A (en) * 1991-10-25 1996-07-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolopyridazines having gastrointestinal protective effects
ES2185693T3 (es) * 1994-01-19 2003-05-01 Sankyo Co Derivado de pirrolopiridacina.
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
CZ292349B6 (cs) 2003-09-17
CN1284078A (zh) 2001-02-14
HK1030216A1 (en) 2001-04-27
HUP0100601A3 (en) 2002-10-28
US6518270B1 (en) 2003-02-11
TW515798B (en) 2003-01-01
NO20002721L (no) 2000-07-28
AR016972A1 (es) 2001-08-01
HUP0100601A2 (hu) 2001-09-28
TR200001530T2 (tr) 2000-11-21
PL340920A1 (en) 2001-03-12
JP2001525322A (ja) 2001-12-11
ID24730A (id) 2000-08-03
BR9814755A (pt) 2000-10-03
PT1042324E (pt) 2003-06-30
ES2191356T3 (es) 2003-09-01
CA2311798A1 (en) 1999-06-10
SK6742000A3 (en) 2001-03-12
EE200000315A (et) 2001-10-15
EP1042324A1 (en) 2000-10-11
RU2241000C2 (ru) 2004-11-27
NO20002721D0 (no) 2000-05-26
AU752187C (en) 2003-09-18
ZA9810468B (en) 1999-05-21
IS5486A (is) 2000-05-10
IL136145A0 (en) 2001-05-20
MY121032A (en) 2005-12-30
EE04060B1 (et) 2003-06-16
NO315704B1 (no) 2003-10-13
AU752187B2 (en) 2002-09-12
CN1142933C (zh) 2004-03-24
WO1999028322A1 (en) 1999-06-10
ATE233263T1 (de) 2003-03-15
DE69811735T2 (de) 2003-12-18
CZ20001947A3 (cs) 2000-11-15
SK283904B6 (sk) 2004-04-06
EP1042324B1 (en) 2003-02-26
UA70932C2 (uk) 2004-11-15
KR20010032559A (ko) 2001-04-25
AU1356599A (en) 1999-06-16
DK1042324T3 (da) 2003-05-05
NZ504355A (en) 2001-12-21
DE69811735D1 (de) 2003-04-03

Similar Documents

Publication Publication Date Title
SE9704404D0 (sv) New compounds
SE9700661D0 (sv) New compounds
SE9801526D0 (sv) New compounds
SE9602286D0 (sv) New compounds
SE9802794D0 (sv) New compounds
NZ510180A (en) Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors
FI970246A7 (fi) Dihydrobentsofuraanit
SE9802793D0 (sv) New compounds
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
SE0102808D0 (sv) New compounds
NO995289L (no) Benzimidazol-derivater
ATE196134T1 (de) Substituierte chinolinderivate, und ihre verwendung als inhibitoren der magensekretion
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect